Reduction of NT-proBNP in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction in short-term treatment with empagliflozin on top of existing therapy
Event:
Heart Failure 2019
Topic:
Pharmacotherapy
Session:
Chronic Heart Failure – Treatment